Patents by Inventor Matthew O'Reilly
Matthew O'Reilly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220353090Abstract: A medical treatment machine, such as a dialysis machine (e.g., a home dialysis machine, such as a home hemodialysis machine or a home peritoneal dialysis machine) can receive a digital prescription file that defines parameters of a medical treatment to be administered to a patient. The digital prescription file can be prepared and delivered in such a way that the medical treatment machine can confirm that the issuer (e.g., provider) of the digital prescription file is an authorized issuer without having any a priori knowledge of the particular issuer. The digital prescription file can be delivered irrespective of the inherent security (or lack thereof) of the transmission medium in a tamper-evident format using minimal resources necessary to verify the validity of the digital prescription file and its issuer. The digital prescription file may be delivered to the dialysis machine using a network cloud-based connected health system.Type: ApplicationFiled: July 14, 2022Publication date: November 3, 2022Inventors: Harvey Cohen, Matthew Buraczenski, Matthew O'Reilly
-
Patent number: 11424934Abstract: A medical treatment machine, such as a dialysis machine (e.g., a home dialysis machine, such as a home hemodialysis machine or a home peritoneal dialysis machine) can receive a digital prescription file that defines parameters of a medical treatment to be administered to a patient. The digital prescription file can be prepared and delivered in such a way that the medical treatment machine can confirm that the issuer (e.g., provider) of the digital prescription file is an authorized issuer without having any a priori knowledge of the particular issuer. The digital prescription file can be delivered irrespective of the inherent security (or lack thereof) of the transmission medium in a tamper-evident format using minimal resources necessary to verify the validity of the digital prescription file and its issuer. The digital prescription file may be delivered to the dialysis machine using a network cloud-based connected health system.Type: GrantFiled: March 4, 2020Date of Patent: August 23, 2022Assignee: Fresenius Medical Care Holdings, Inc.Inventors: Harvey Cohen, Matthew Buraczenski, Matthew O'Reilly
-
Publication number: 20200259664Abstract: A medical treatment machine, such as a dialysis machine (e.g., a home dialysis machine, such as a home hemodialysis machine or a home peritoneal dialysis machine) can receive a digital prescription file that defines parameters of a medical treatment to be administered to a patient. The digital prescription file can be prepared and delivered in such a way that the medical treatment machine can confirm that the issuer (e.g., provider) of the digital prescription file is an authorized issuer without having any a priori knowledge of the particular issuer. The digital prescription file can be delivered irrespective of the inherent security (or lack thereof) of the transmission medium in a tamper-evident format using minimal resources necessary to verify the validity of the digital prescription file and its issuer. The digital prescription file may be delivered to the dialysis machine using a network cloud-based connected health system.Type: ApplicationFiled: March 4, 2020Publication date: August 13, 2020Inventors: Harvey Cohen, Matthew Buraczenski, Matthew O`Reilly
-
Patent number: 10623188Abstract: A medical treatment machine, such as a dialysis machine (e.g., a home dialysis machine, such as a home hemodialysis machine or a home peritoneal dialysis machine) can receive a digital prescription file that defines parameters of a medical treatment to be administered to a patient. The digital prescription file can be prepared and delivered in such a way that the medical treatment machine can confirm that the issuer (e.g., provider) of the digital prescription file is an authorized issuer without having any a priori knowledge of the particular issuer. The digital prescription file can be delivered irrespective of the inherent security (or lack thereof) of the transmission medium in a tamper-evident format using minimal resources necessary to verify the validity of the digital prescription file and its issuer. The digital prescription file may be delivered to the dialysis machine using a network cloud-based connected health system.Type: GrantFiled: April 26, 2017Date of Patent: April 14, 2020Assignee: Fresenius Medical Care Holdings, Inc.Inventors: Harvey Cohen, Matthew Buraczenski, Matthew O'Reilly
-
Publication number: 20180316505Abstract: A medical treatment machine, such as a dialysis machine (e.g., a home dialysis machine, such as a home hemodialysis machine or a home peritoneal dialysis machine) can receive a digital prescription file that defines parameters of a medical treatment to be administered to a patient. The digital prescription file can be prepared and delivered in such a way that the medical treatment machine can confirm that the issuer (e.g., provider) of the digital prescription file is an authorized issuer without having any a priori knowledge of the particular issuer. The digital prescription file can be delivered irrespective of the inherent security (or lack thereof) of the transmission medium in a tamper-evident format using minimal resources necessary to verify the validity of the digital prescription file and its issuer. The digital prescription file may be delivered to the dialysis machine using a network cloud-based connected health system.Type: ApplicationFiled: April 26, 2017Publication date: November 1, 2018Inventors: Harvey Cohen, Matthew Buraczenski, Matthew O'Reilly
-
Patent number: 9765102Abstract: Embodiments of the invention are directed to ONO pincer ligands that can be in a trianionic, protonated or protonated equivalent form. The ONO pincer ligand can be combined with a metal comprising compound to form an ONO pincer ligand comprising transition metal complex. By choice of the ONO pincer ligand structure, the steric and electronic properties of the metal complexes therefrom can be controlled. The ONO pincer ligands comprise a central nitrogen atom that is disubstituted with a pair of three atom comprising bridges where the three atoms are a pair of sp2 hybridized carbons and an sp3 hybridized carbon.Type: GrantFiled: October 6, 2016Date of Patent: September 19, 2017Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.Inventors: Adam Steven Veige, Matthew O'Reilly
-
Publication number: 20170022230Abstract: Embodiments of the invention are directed to ONO pincer ligands that can be in a trianionic, protonated or protonated equivalent form. The ONO pincer ligand can be combined with a metal comprising compound to form an ONO pincer ligand comprising transition metal complex. By choice of the ONO pincer ligand structure, the steric and electronic properties of the metal complexes therefrom can be controlled. The ONO pincer ligands comprise a central nitrogen atom that is disubstituted with a pair of three atom comprising bridges where the three atoms are a pair of sp2 hybridized carbons and an sp3 hybridized carbon.Type: ApplicationFiled: October 6, 2016Publication date: January 26, 2017Inventors: Adam Steven Veige, Matthew O'Reilly
-
Patent number: 9464104Abstract: Embodiments of the invention are directed to ONO pincer ligands that can be in a trianionic, protonated or protonated equivalent form. The ONO pincer ligand can be combined with a transition metal comprising compound to form an ONO pincer ligand comprising transition metal complex. By choice of the ONO pincer ligand structure, the steric and electronic properties of the transition metal complexes therefrom can be controlled. The ONO pincer ligands comprise a central nitrogen atom that is disubstituted with a pair of three atom comprising bridges where the three atoms are three sp2 hybridized carbons or the three atoms are a pair of sp2 hybridized carbons and an sp3 hybridized carbon or silicon.Type: GrantFiled: November 12, 2013Date of Patent: October 11, 2016Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.Inventors: Adam Steven Veige, Matthew O'Reilly, Muhammad Tariq Jan
-
Patent number: 9154515Abstract: Information security may include defending information from unauthorized access, use, disclosure, modification, destruction, and so forth. Described herein are systems, methods and devices for enabling a user device to implement functions for dynamically identifying and reacting to potentially malicious activity. In one example, a user device configures a sentinel node to identify potentially malicious behavior by causing the sentinel node to analyze data from selected emitter nodes and selected algorithms. The user device may also specify how the sentinel node reacts to potential malicious activity.Type: GrantFiled: December 19, 2013Date of Patent: October 6, 2015Assignee: Amazon Technologies, Inc.Inventors: Francesco Russo, Dominique Imjya Brezinski, Robert Hanna Mahfoud, Martin Matthew O'Reilly
-
Patent number: 8846950Abstract: An embodiment of the invention is a novel Cr(V)OCO3? trianionic pincer ligand complex. Another embodiment of the invention is a catalytic method for oxidation of a substrate aerobically in the presence of a source of oxygen, where the novel Cr(V)OCO3? trianionic pincer ligand complex acts as the catalyst. The substrate can be a phosphine, amine, sulfide, alkene, alkane or a second metal complex. Another embodiment of the invention is directed to NCN pincer ligands that can form trianionic pincer ligand complexes.Type: GrantFiled: March 3, 2010Date of Patent: September 30, 2014Assignee: University of Florida Research Foundation, Inc.Inventors: Adam Steven Veige, Joseph Michael Falkowski, Matthew O'Reilly, Subramaniam Kuppuswamy, Kevin P. McGowan, Soumya Sarkar
-
Publication number: 20140073800Abstract: Embodiments of the invention are directed to ONO pincer ligands that can be in a trianionic, protonated or protonated equivalent form. The ONO pincer ligand can be combined with a transition metal comprising compound to form an ONO pincer ligand comprising transition metal complex. By choice of the ONO pincer ligand structure, the steric and electronic properties of the transition metal complexes therefrom can be controlled. The ONO pincer ligands comprise a central nitrogen atom that is disubstituted with a pair of three atom comprising bridges where the three atoms are three sp2 hybridized carbons or the three atoms are a pair of sp2 hybridized carbons and an sp3 hybridized carbon or silicon.Type: ApplicationFiled: November 12, 2013Publication date: March 13, 2014Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.Inventors: ADAM STEVEN VEIGE, MATTHEW O'REILLY, MUHAMMAD TARIQ JAN
-
Publication number: 20110313174Abstract: An embodiment of the invention is a novel Cr(V) OCO3- trianionic pincer ligand complex. Another embodiment of the invention is a catalytic method for oxidation of a substrate aerobically in the presence of a source of oxygen, where the novel Cr(V) OCO3- trianionic pincer ligand complex acts as the catalyst. The substrate can be a phosphine, amine, sulfide, alkene, alkane or a second metal complex. Another embodiment of the invention is directed to NCN pincer ligands that can form trianionic pincer ligand complexes.Type: ApplicationFiled: March 3, 2010Publication date: December 22, 2011Applicant: University of Florida Research Foundation, Inc.Inventors: Adam Steven Veige, Joseph Michael Falkowski, Matthew O'Reilly, Subramaniam Kuppuswamy, Kevin P. McGowan, Soumya Sarkar